HLS Therapeutics Semi Deviation
| HLS Stock | | | CAD 4.40 0.01 0.23% |
The Semi Deviation indicator for HLS Therapeutics is constructed from normalized market data. The
Equity Screeners module supports multi-indicator technical analysis. HLS Therapeutics has a market cap of 137.6 M, operating margin of 1.56%, current ratio of 1.7. Review
Risk vs Return Analysis for broader portfolio context. Tracking HLS Therapeutics in a portfolio helps measure its contribution to overall performance. Position weights are derived from the selected portfolio construction methodology. Broader economic conditions can influence HLS Therapeutics's company valuation — related indicators include
signals in inflation.
HLS Therapeutics has current Semi Deviation of 0. Semi-deviation provides a good measure of downside risk for a equity or a portfolio. It is similar to standard deviation, but it only looks at periods where the returns are less than the target or average level.
Semi Deviation | = | SQRT(SV) |
| = | 0 | |
Semi Deviation Peers Comparison
Semi Deviation Relative To Other Indicators
HLS Therapeutics is rated
below average in semi deviation compared to key competitors. It is currently under evaluation in maximum drawdown compared to key competitors .
Semi-deviation is the square root of semi-variance. Semi-variance is calculated by averaging the deviations of returns that have a result that is less than the mean.
Compare HLS Therapeutics to Peers
Other Technical Indicators